Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys

Abstract

Background Describing the prevalence and trends of cardiometabolic risk factors that are associated with noncommunicable diseases (NCDs) is crucial for monitoring progress, planning prevention, and providing evidence to support policy efforts. We aimed to analyse the transition in body-mass index (BMI), obesity, blood pressure, raised blood pressure, and diabetes in the Americas, between 1980 and 2014.Methods We did a pooled analysis of population-based studies with data on anthropometric measurements, biomarkers for diabetes, and blood pressure from adults aged 18 years or older. A Bayesian model was used to estimate trends in BMI, raised blood pressure (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg), and diabetes (fasting plasma glucose ≥7•0 mmol/L, history of diabetes, or diabetes treatment) from 1980 to 2014, in 37 countries and six subregions of the Americas. Findings 389 population-based surveys from the Americas were available. Comparing prevalence estimates from 2014 with those of 1980, in the non-English speaking Caribbean subregion, the prevalence of obesity increased from 3•9% (95% CI 2•2-6•3) in 1980, to 18•6% (14•3-23•3) in 2014, in men; and from 12•2% (8•2-17•0) in 1980, to 30•5% (25•7-35•5) in 2014, in women. The English-speaking Caribbean subregion had the largest increase in the prevalence of diabetes, from 5•2% (2•1-10•4) in men and 6•4% (2•6-10•4) in women in 1980, to 11•1% (6•4-17•3) in men and 13•6% (8•2-21•0) in women in 2014). Conversely, the prevalence of raised blood pressure has decreased in all subregions; the largest decrease was found in North America from 27•6% (22•3-33•2) in men and 19•9% (15•8-24•4) in women in 1980, to 15•5% (11•1-20•9) in men and 10•7% (7•7-14•5) in women in 2014. Interpretation Despite the generally high prevalence of cardiometabolic risk factors across the Americas, estimates also showed a high level of heterogeneity in the transition between countries. The increasing prevalence of obesity and diabetes observed over time requires appropriate measures to deal with these public health challenges. Our results support a diversification of health interventions across subregions and countries. Funding Wellcome Trust.

Nutritional Viewpoints on Eggs and Cholesterol

“…In this context, eating white potatoes with eggs appears to control glycemic response [112]. There is an increasing prevalence of obesity and DM in the US during these decades [113,114]. The different responses to egg consumption between the US and other countries are probably attributable to residual confounding by dietary behaviors or food preparation methods restricted to certain populations.…”

High prevalence of childhood overweight and obesity in ten Caribbean countries: 2018 cross-sectional data and a narrative review of trends in Trinidad and Tobago

“…The 2016 data further placed the Caribbean amongst the regions with the highest mean BMI for the ages 5-19 years (NCD-RisC 2017). Whilst we are cautious of interpreting the ranking of countries given the modest sample sizes based on our sampling frame, it is interesting to note that Grenada which had the lowest combined O&O prevalence had dedicated its "One Health One Caribbean One Love" project a few years earlier specifically towards reducing childhood obesity, whereas other Caribbean countries addressed other sustainable development goals (Oura et al 2017).…”

Clusters of people with type 2 diabetes in the general population: unsupervised machine learning approach using national surveys in Latin America and the Caribbean

“…This could signal different profiles of people with T2DM in these countries (eg, metabolic control) and different distributions of underlying risk factors (eg, obesity). 3 Health system performance to prevent, diagnose and control T2DM could also potentially explain this finding. Nonetheless, we ought to keep in mind a key difference among the analyzed data sets: the age structure.…”

“…This suggests that the characteristics of people with T2DM do not distribute equally in the selected countries. 3 This has implications for regional and national interventions. First, regional guidelines and recommendations should secure that, when relevant and possible, interventions are tailored or can be adapted to the reality or profile of each country.…”